Oramed Pharmaceuticals
ORMP
#9122
Rank
ยฃ0.12 B
Marketcap
ยฃ3.02
Share price
-3.12%
Change (1 day)
77.64%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): ยฃ58.3 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of ยฃ58.44 Million, an increase over its 2024 earnings that were of -ยฃ11.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ58.3 M-0.25%
2025 ยฃ58.44 M-616.9%
2024 -ยฃ11.31 Million-311.47%
2023 ยฃ5.34 M-119.45%
2022 -ยฃ27.49 Million39.17%
2021 -ยฃ19.76 Million73.93%
2020 -ยฃ11.36 Million18.53%
2019 -ยฃ9.59 Million-16.62%
2018 -ยฃ11.49 Million38.32%
2017 -ยฃ8.31 Million12.51%
2016 -ยฃ7.39 Million25.01%
2015 -ยฃ5.91 Million18.18%
2014 -ยฃ5 Million39.72%
2013 -ยฃ3.58 Million46.4%
2012 -ยฃ2.45 Million128.32%
2011 -ยฃ1.08 Million-51.47%
2010 -ยฃ2.21 Million35.21%
2009 -ยฃ1.64 Million
2007 -ยฃ2.57 Million607.04%
2006 -ยฃ0.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
ยฃ18.76 B 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
ยฃ5.74 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-ยฃ0.41 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-ยฃ19.58 Million-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
ยฃ26.17 M-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel